Literature DB >> 29730428

The expression and function of PAX3 in development and disease.

Salah Boudjadi1, Bishwanath Chatterjee1, Wenyue Sun1, Prasantha Vemu1, Frederic G Barr2.   

Abstract

The PAX3 gene encodes a member of the PAX family of transcription factors that is characterized by a highly conserved paired box motif. The PAX3 protein is a transcription factor consisting of an N-terminal DNA binding domain (containing a paired box and homeodomain) and a C-terminal transcriptional activation domain. This protein is expressed during development of skeletal muscle, central nervous system and neural crest derivatives, and regulates expression of target genes that impact on proliferation, survival, differentiation and motility in these lineages. Germline mutations of the murine Pax3 and human PAX3 genes cause deficiencies in these developmental lineages and result in the Splotch phenotype and Waardenburg syndrome, respectively. Somatic genetic rearrangements that juxtapose the PAX3 DNA binding domain to the transcriptional activation domain of other transcription factors deregulate PAX3 function and contribute to the pathogenesis of the soft tissue cancers alveolar rhabdomyosarcoma and biphenotypic sinonasal sarcoma. The wild-type PAX3 protein is also expressed in other cancers related to developmental lineages that normally express this protein and exerts phenotypic effects related to its normal developmental role.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Alternative splicing; Central nervous system development; Fusion oncoprotein; Homeodomain; Melanocyte; Melanoma; Neural crest; Paired box; Rhabdomyosarcoma; Skeletal muscle development; Soft tissue sarcoma; Splotch; Target gene; Transcription factor; Waardenburg syndrome

Mesh:

Substances:

Year:  2018        PMID: 29730428      PMCID: PMC6624083          DOI: 10.1016/j.gene.2018.04.087

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  24 in total

1.  PAX3 Promotes Proliferation of Human Glioma Cells by WNT/β-Catenin Signaling Pathways.

Authors:  Xia Liang; Zhao Dong; Wu Bin; Nie Dekang; Zhu Xuhang; Zhang Shuyuan; Li Liwen; Jin Kai; Sun Caixing
Journal:  J Mol Neurosci       Date:  2019-03-02       Impact factor: 3.444

2.  Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer.

Authors:  Doo Byung Chay; Gwan Hee Han; Sanghee Nam; Hanbyoul Cho; Joon-Yong Chung; Stephen M Hewitt
Journal:  Int J Clin Oncol       Date:  2019-07-13       Impact factor: 3.402

3.  Genome-wide association study of cerebellar volume provides insights into heritable mechanisms underlying brain development and mental health.

Authors:  Elleke Tissink; Siemon C de Lange; Jeanne E Savage; Douglas P Wightman; Christiaan A de Leeuw; Kristen M Kelly; Mats Nagel; Martijn P van den Heuvel; Danielle Posthuma
Journal:  Commun Biol       Date:  2022-07-16

4.  Pax3 Hypomorphs Reveal Hidden Pax7 Functional Genetic Compensation in Utero.

Authors:  Hong-Ming Zhou; Simon J Conway
Journal:  J Dev Biol       Date:  2022-05-17

5.  Fusion of the Paired Box 3 (PAX3) and Myocardin (MYOCD) Genes in Pediatric Rhabdomyosarcoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Marius Lund-Iversen; Svetlana Tafjord; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 Nov-Dec       Impact factor: 4.069

Review 6.  Genetic insights, disease mechanisms, and biological therapeutics for Waardenburg syndrome.

Authors:  Sida Huang; Jian Song; Chufeng He; Xinzhang Cai; Kai Yuan; Lingyun Mei; Yong Feng
Journal:  Gene Ther       Date:  2021-02-25       Impact factor: 4.184

7.  Expression of unfolded protein response markers in the pheochromocytoma with Waardenburg syndrome: a case report.

Authors:  Shuhei Morita; Ken Takeshima; Hiroyuki Ariyasu; Yasushi Furukawa; Shohei Kishimoto; Tomoya Tsuji; Shinsuke Uraki; Hiroyuki Mishima; Akira Kinoshita; Yuichi Takahashi; Hidefumi Inaba; Hiroshi Iwakura; Hiroto Furuta; Masahiro Nishi; Asako Doi; Shin-Ichi Murata; Koh-Ichiro Yoshiura; Takashi Akamizu
Journal:  BMC Endocr Disord       Date:  2020-06-22       Impact factor: 2.763

8.  A novel PAX3 mutation in a Korean patient with Waardenburg syndrome type 1 and unilateral branch retinal vein and artery occlusion: a case report.

Authors:  Eun Young Choi; Wungrak Choi; Christopher Seungkyu Lee
Journal:  BMC Ophthalmol       Date:  2018-10-11       Impact factor: 2.209

Review 9.  Do Defective Immune System-Mediated Myelination Processes Increase Postpartum Psychosis Risk?

Authors:  Paola Dazzan; Montserrat Fusté; William Davies
Journal:  Trends Mol Med       Date:  2018-10-19       Impact factor: 15.272

10.  High Genetic Heterogeneity in Chinese Patients With Waardenburg Syndrome Revealed by Next-Generation Sequencing.

Authors:  Sen Zhang; Hongen Xu; Yongan Tian; Danhua Liu; Xinyue Hou; Beiping Zeng; Bei Chen; Huanfei Liu; Ruijun Li; Xiaohua Li; Bin Zuo; Ryan Tang; Wenxue Tang
Journal:  Front Genet       Date:  2021-06-04       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.